GSK’s Nucala gains US use in rare autoimmune diseaseIL-5 drug approved in EGPA Share XGSK’s Nucala gains US use in rare autoimmune diseasehttps://pharmaphorum.com/news/gsks-nucala-gains-us-use-rare-autoimmune-disease/
